ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs
膀胱和阴道上皮细胞小窝在尿路感染中的作用
基本信息
- 批准号:7092010
- 负责人:
- 金额:$ 17.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-01 至 2008-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Urinary tract infections (UTIs) in women begin with the attachment of infecting microorganisms to vaginal and subsequently to bladder epithelium. In our prior studies, we utilized primary bladder epithelial cell (BEC) cultures as a model to define the role and regulation of glycosphingolipids (GSLs) as attachment sites for uropathogenic E. coli, later extending these studies to a new model of primary vaginal epithelial cell (VEC) cultures. GSLs do not occur randomly in cell membranes, but instead are organized into specialized membrane domains such as caveolae, characterized by enrichment in cholesterol, sphingomyelin, glycolipids such as ganglioside GM1, lipid-anchored proteins, and caveolin. These domains are involved in a wide variety of key cellular functions, including transport of cholesterol, macromolecular solute transport, tumor suppression, and signal transduction.
Recent evidence demonstrates that caveolae are key molecules in the initial host response to attaching uropathogenic E. coli in mast cells, mediating the uptake of organisms. We have preliminary data demonstrating that caveolin-1 is present in primary cultured VEC and BEC monolayers and native vaginal tissue sections, and that native vaginal epithelial cells contain GM1, a key GSL of caveolae in mast cells and other tissues. The central hypothesis of this proposal is that caveolae occur in bladder and vaginal epithelium and participate in the initial epithelial responses to attachment of uropathogenic E. coli. We will pursue the following specific aims: (I) To conclusively demonstrate that caveolae occur in bladder and vaginal epithelium, we will structurally and biochemically characterize these structures in primary cultured BEC and VEC, including defining GSLs localized to caveolae in these cells; (2) To address the hypothesis that caveolae contain key receptor molecules for uropathogenic E. coli, we will determine if caveolin co-localizes with the globoseries GSLs in primary cultured BEC and VEC and/or with mannosylated glycoproteins that bind Type 1 fimbriated E. coli; (3) To investigate the hypothesis that caveolae mediate uptake of Type 1 fimbriated E. coli into urogenital epithelium, we will investigate invasion of cultured primary human BEC by this organism, testing for colocalization of engulfed bacteria with caveolar markers and investigating if disruption of caveolae prevents bacterial uptake; and (4) using established neo-organ models of bladder and vaginal epithelium, we will demonstrate key findings from the monolayer systems, such as the presence of caveolae, bacterial invasion, and mediation of this process by caveolae. These studies will advance knowledge of the role of GSLs and caveolae, fundamental cellular components, in the pathogenesis of E. coli UTI.
描述(由申请方提供):女性尿路感染(UTI)开始是感染微生物附着于阴道,随后附着于膀胱上皮。在我们之前的研究中,我们利用原代膀胱上皮细胞(BEC)培养物作为模型来确定鞘糖脂(GSL)作为尿路致病性大肠杆菌附着位点的作用和调节。大肠杆菌,后来将这些研究扩展到原代阴道上皮细胞(VEC)培养的新模型。GSL不是随机出现在细胞膜中,而是组织成专门的膜结构域,如小窝,其特征在于富含胆固醇、鞘磷脂、糖脂如神经节苷脂GM 1、脂质锚定蛋白和小窝蛋白。这些结构域参与多种关键细胞功能,包括胆固醇转运、大分子溶质转运、肿瘤抑制和信号转导。
最近的证据表明,窖是宿主对尿路致病性大肠杆菌的初始反应的关键分子。肥大细胞中的大肠杆菌,介导生物体的摄取。我们有初步的数据表明,小窝蛋白-1存在于原代培养的VEC和BEC单层和天然阴道组织切片,天然阴道上皮细胞含有GM 1,肥大细胞和其他组织中小窝的关键GSL。该假说的中心假设是,小窝发生在膀胱和阴道上皮中,并参与上皮对致尿病性大肠杆菌附着的初始反应。杆菌我们将追求以下具体目标:(1)为了最终证明小窝发生在膀胱和阴道上皮中,我们将在原代培养的BEC和VEC中对这些结构进行结构和生化表征,包括定义这些细胞中定位于小窝的GSL;(2)为了解决小窝包含尿路致病性E.大肠杆菌中,我们将确定窖蛋白是否与原代培养的BEC和VEC中的球状系列GSL和/或与结合1型菌毛大肠杆菌的甘露糖基化糖蛋白共定位。(3)探讨Caveolae介导1型菌毛大肠杆菌摄取的假说。大肠杆菌进入泌尿生殖道上皮,我们将研究这种微生物对培养的原代人BEC的侵袭,测试吞噬细菌与小窝标记物的共定位,并研究小窝的破坏是否阻止细菌摄取;以及(4)使用已建立的膀胱和阴道上皮的新器官模型,我们将证明来自单层系统的关键发现,例如小窝的存在,细菌侵入,并通过小凹来调节这一过程。这些研究将进一步了解GSL和小窝,基本的细胞成分,在发病机制中的作用。coli UTI。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ann E Stapleton其他文献
Ann E Stapleton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ann E Stapleton', 18)}}的其他基金
Lactobacillus probiotic for prevention of recurrent UTI
乳酸菌益生菌预防复发性尿路感染
- 批准号:
8528569 - 财政年份:2011
- 资助金额:
$ 17.46万 - 项目类别:
Lactobacillus probiotic for prevention of recurrent UTI
乳酸菌益生菌预防复发性尿路感染
- 批准号:
8332134 - 财政年份:2011
- 资助金额:
$ 17.46万 - 项目类别:
Lactobacillus probiotic for prevention of recurrent UTI
乳酸菌益生菌预防复发性尿路感染
- 批准号:
8706851 - 财政年份:2011
- 资助金额:
$ 17.46万 - 项目类别:
Lactobacillus probiotic for prevention of recurrent UTI
乳酸菌益生菌预防复发性尿路感染
- 批准号:
8108248 - 财政年份:2011
- 资助金额:
$ 17.46万 - 项目类别:
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs
膀胱和阴道上皮细胞小窝在尿路感染中的作用
- 批准号:
6797120 - 财政年份:2003
- 资助金额:
$ 17.46万 - 项目类别:
ROLE OF BLADDER AND VAGINAL EPITHELIAL CAVEOLAE IN UTIs
膀胱和阴道上皮细胞小窝在尿路感染中的作用
- 批准号:
7257245 - 财政年份:2003
- 资助金额:
$ 17.46万 - 项目类别:
相似海外基金
A human slice model to understand the role of fibrosis in children with bladder exstrophy
人体切片模型了解纤维化在膀胱外翻儿童中的作用
- 批准号:
MR/X030946/1 - 财政年份:2024
- 资助金额:
$ 17.46万 - 项目类别:
Research Grant
Development of a comprehensive microbial immunotherapy platform with immuno-transcriptomic monitoring for treatment of bladder cancer (DOCMI-BC)
开发用于治疗膀胱癌的具有免疫转录组监测的综合微生物免疫治疗平台(DOCMI-BC)
- 批准号:
10087336 - 财政年份:2024
- 资助金额:
$ 17.46万 - 项目类别:
Collaborative R&D
BBconnect - a people-centred, system aware design feasibility investigation that aims to define innovation opportunities, generate and evaluate viable ideas for more accessible, effective and integrated bladder and bowel healthcare services.
BBconnect - 一项以人为本、系统意识的设计可行性调查,旨在定义创新机会,生成和评估可行的想法,以提供更方便、有效和综合的膀胱和肠道医疗保健服务。
- 批准号:
10089501 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Collaborative R&D
NIMBLE - an artificial intelligence-based early warning system for bladder cancer
NIMBLE——基于人工智能的膀胱癌早期预警系统
- 批准号:
486937 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Miscellaneous Programs
Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood
雌性小鼠生命早期的膀胱炎症事件导致成年后的 LUTS
- 批准号:
10638866 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
A Robotic System to Remove Bladder Tumors Intact: The Key to Making Lifesaving Treatment Decisions
完整切除膀胱肿瘤的机器人系统:做出救生治疗决策的关键
- 批准号:
10760853 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome
间质性膀胱炎/膀胱疼痛综合征的机械治疗
- 批准号:
10659814 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Investigating mechanisms of bladder cancer metastasis
研究膀胱癌转移的机制
- 批准号:
10718278 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别:
Replacing Invasive Cystoscopy with Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
用尿液检测代替侵入性膀胱镜检查进行非肌肉侵入性膀胱癌监测
- 批准号:
10559724 - 财政年份:2023
- 资助金额:
$ 17.46万 - 项目类别: